Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease

被引:3
|
作者
Hashimoto, Ikuo [1 ]
机构
[1] Toyama City Hosp, Dept Pediat, 2-1 Hokubu Mach, Toyama, Toyama 9398511, Japan
关键词
hyponatremia; i; v; immunoglobulin; Kawasaki disease; GAMMA-GLOBULIN; CYTOKINE PROFILES; HYPONATREMIA; PREDICTION; RESISTANCE; SECRETION; THERAPY; FAILURE;
D O I
10.1111/ped.13898
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background The aim of this study was to identify the indicators of unresponsiveness to initial i.v. immunoglobulin (IVIG) treatment for Kawasaki disease (KD). Methods One hundred and forty-five patients with KD, who had received initial treatment consisting of a single IVIG dose (1 g/kg or 2 g/kg) and oral aspirin (30 mg/kg), were studied. Laboratory parameters, including C-reactive protein (CRP) and serum sodium (Na), were measured before and after IVIG treatment, and during the convalescent phase, and the laboratory data compared with regards to IVIG response. Multiple logistic regression models, which included laboratory data obtained immediately after the IVIG treatment, were constructed to determine the indicators of IVIG unresponsiveness immediately after the completion of the initial treatment. Results On logistic regression analysis, serum Na after IVIG treatment was the only independent factor related to initial IVIG unresponsiveness (beta = 0.53, P < 0.01; OR, 1.69; 95%CI: 1.15-2.49). On receiver operating characteristic curve analysis, the optimal serum Na cut-off immediately after IVIG treatment was 135.5 mEq/L with a sensitivity of 0.75, and a specificity of 0.79. Conclusions Prolonged hyponatremia after completion of the initial IVIG therapy was an indicator of the need for subsequent IVIG therapy. Treatment plans should be established for patients with acute KD that pay particular attention to prolonged hyponatremia.
引用
收藏
页码:641 / 646
页数:6
相关论文
共 50 条
  • [1] Seasonality of i.v. immunoglobulin responsiveness in Kawasaki disease
    Kido, Shinji
    Ae, Ryusuke
    Kosami, Koki
    Matsubara, Yuri
    Makino, Nobuko
    Sasahara, Teppei
    Kuwabara, Masanari
    Aoyama, Yasuko
    Yashiro, Mayumi
    Yanagawa, Hiroshi
    Nakamura, Yosikazu
    PEDIATRICS INTERNATIONAL, 2019, 61 (06) : 539 - 543
  • [2] Marked pleural effusion after i.v. immunoglobulin therapy for Kawasaki disease
    Koizumi, Keiichi
    Hoshiai, Minako
    Toda, Takako
    Nakane, Takaya
    Sugita, Kanji
    PEDIATRICS INTERNATIONAL, 2018, 60 (03) : 307 - 308
  • [3] Predictors Of Unresponsiveness To Initial Immunoglobulin In Patients With Kawasaki Disease
    Yu, Jeong Jin
    Cho, Eun Kyung
    Jun, Hyun Ok
    Kang, So Yeon
    Seo, Chang Deok
    Baek, Jae Suk
    Kim, Young-Hwue
    Ko, Jae-Kon
    CIRCULATION, 2015, 131
  • [4] Adult Kawasaki disease: Evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment
    Fujimoto, Noriki
    Teramura, Kazuya
    Tanaka, Toshihiro
    JOURNAL OF DERMATOLOGY, 2012, 39 (11): : 957 - 958
  • [5] Effect of i.v. immunoglobulin in the first 4 days of illness in Kawasaki disease
    Shiozawa, Yusuke
    Inuzuka, Ryo
    Shindo, Takahiro
    Mafune, Ryo
    Hayashi, Taiyu
    Hirata, Yoichiro
    Shimizu, Nobutaka
    Inatomi, Jun
    Yokoyama, Yoshiki
    Namai, Yoshiyuki
    Oda, Yoichiro
    Takamizawa, Masaru
    Harita, Yutaka
    Kawahara, Takuya
    Oka, Akira
    PEDIATRICS INTERNATIONAL, 2018, 60 (04) : 334 - 341
  • [6] Drug-induced hypersensitivity syndrome by i.v. immunoglobulin administration for Kawasaki disease
    Satake, Mao
    Kudo, Kyoko
    Masuda, Akiko
    Onoyama, Sagano
    Furuno, Kenji
    Furue, Masutaka
    JOURNAL OF DERMATOLOGY, 2020, 47 (03): : E74 - E75
  • [7] Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease
    Kanamitsu, Kiichiro
    Kakimoto, Hisako
    Shimada, Akira
    Nakata, Yusei
    Ochi, Hiroaki
    Watanabe, Hirokazu
    Iwasaki, Yuka
    Tokorodani, Chiho
    Kanazawa, Akane
    Maruyama, Hidehiko
    Miyazawa, Mari
    Nishiuchi, Ritsuo
    Kikkawa, Kiyoshi
    PEDIATRICS INTERNATIONAL, 2016, 58 (02) : 146 - 151
  • [9] Efficacy of Intravenous Immunoglobulin Combined With Prednisolone for Resistance to Initial Immunoglobulin Treatment of Acute Kawasaki Disease
    Kobayashi, Tohru
    Kobayashi, Tomio
    Morikawa, Akihiro
    Ikeda, Kentaro
    Seki, Mitsuru
    Shimoyama, Shinya
    Ishii, Yoichiro
    Suzuki, Takahiro
    Nakajima, Kimiko
    Sakamoto, Naoko
    Arakawa, Hirokazu
    CIRCULATION, 2012, 126 (21)
  • [10] Crucial transcripts predict response to initial immunoglobulin treatment in acute Kawasaki disease
    Zhimin Geng
    Jingjing Liu
    Jian Hu
    Ying Wang
    Yijing Tao
    Fenglei Zheng
    Yujia Wang
    Songling Fu
    Wei Wang
    Chunhong Xie
    Yiying Zhang
    Fangqi Gong
    Scientific Reports, 10